Consumer Tech (Nov 16-20): Anthropic Makes A Smashing Debut, GTA 6 Releases & More
Trump reportedly urges Europe to stop funding Ukraine, while his administration approves nearly 900,000 Nvidia and AMD AI chips for Chinese companies.
Last updated: 2026-11-22 22:55:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
DataMeds AI, Inc. (MEDS) operates in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector and is listed on NASDAQ. The stock is currently priced at $1.33, with a market capitalization of $7.67M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.49 to $12.31. This page covers its latest market performance, valuation, price trends and company information.
$7.67M | |
$0.99 | |
$1.41 | |
$0.87 | |
$0.73 | |
74.50M | |
8.65M | |
-- | |
$12.31 | |
$0.49 | |
-- | |
2026-06-30 |
DataMeds AI, Inc. (MEDS) last closed at $1.33 as of 2026-11-21 01:01:00, up 82.08% ($0.60) from the previous close of $0.73.
During the latest regular trading session, MEDS traded between $0.87 and $1.41, with a volume of 74.50M shares. The closing price was near the upper end and near the lower end of its 52-week range.
Over the past seven days, DataMeds AI, Inc. (MEDS) moved from $0.87 to $1.33, representing a gain of 52.38% ($0.46).
The stock traded between $0.49 and $1.43 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 18.36 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 7.1%
MEDS is currently trading at $1.33, placing it 7.1% of the way from its 52-week low of $0.49 to its 52-week high of $12.31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for pharmacies, wholesale distribution, and a fulfillment network focused on Independent Pharmacies and Specialty Lite medications.
| Industry | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for DataMeds AI, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Jul 19, 2024 |
| Payment Date | Jul 24, 2024 |
| Dividend Per Share | $1.5 |
Latest news related to DataMeds AI, Inc. and MEDS stock.
Trump reportedly urges Europe to stop funding Ukraine, while his administration approves nearly 900,000 Nvidia and AMD AI chips for Chinese companies.
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) stock increased by 16.4% to $3.82 during Friday's after-market session. The market value of their outstanding shares is at $16.1 million. Spectral AI (NASDAQ:MDAI)
Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 44.3% to $1.05 during Friday's regular session. The market value of their outstanding shares is at $4.1 million. Akanda (NASDAQ:AKAN) stock moved upwards by
Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 48.4% to $1.08 during Friday's pre-market session. The company's market cap stands at $4.1 million. Akanda (NASDAQ:AKAN) stock increased by 31.63% to
Gap shares rise 3.8% after Q3 EPS beat estimates; Athleta names new CEO. Erayak and NewGenIvf lead gainers, Solmate leads losers.
Eligible investors can buy real shares of DataMeds AI, Inc. (MEDS) through MEXC Stocks. Follow these three steps to open a Stocks account, transfer USDT, and place a Stocks order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to MEDS, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between MEDS shares and USD.
MEDS Shares to USD
1.00 MEDS shares = 1.326 USD
Calculations are estimates based on the latest available price and are for reference only.